Source - LSE Regulatory
![](https://tracker.live.rns-distribution.com/track.live-rns/5335790_d9353a075fe0b610698e373da828b7e4.png)
RNS Number : 9398C
FTSE Russell
04 September 2024
| |
|
Bivictrix Therapeutics (UK): Constituent Deletion
Changes in FTSE UK Index Series
04 September 2024
Subject to the expected cancellation of trading on AIM for Bivictrix Therapeutics (UK, constituent), please see details of affected indexes and effective dates below:
|
Index | Effective From |
FTSE AIM All-Share Index | 11 September 2024 |
|
For further information please contact FTSE Russell Client Services at info@ftserussell.com or call:
Alternatively please visit our website at lseg.com/ftse-russell
|
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.